© Google Deep mind
April 10, 2026
Marianne Waldenfels
Anti-aging peptides are trending—but do they really work? Learn what studies show, the risks involved, and what to consider before using them
Find a DoctorSearch the network for suitable specialists and contact them directly
Peptides are currently one of the most talked-about topics in anti-aging and longevity. But how effective are so-called longevity peptides—and what risks are often overlooked?
In biohacking circles, they are already being touted as potential “game changers,” promising everything from improved recovery to even a longer lifespan.
At the same time, criticism is growing: many applications go beyond established scientific evidence—and in some cases, beyond clear legal frameworks.
So how much of this is actually backed by research? And where is the line between marketing claims and real risks?
Peptides are short chains of amino acids – essentially 'mini-proteins'. They naturally occur in the body and perform important functions:
In medicine, peptides have long been established – such as insulin for diabetes or certain agents in oncology. What is new, however, is their increasing marketing as an anti-aging and longevity tool.
Many people are already familiar with the term from skincare: Peptides are used in creams and serums to support the skin structure and, for example, stimulate collagen production.
These cosmetic peptides however, work locally in the skin and are not comparable to the systemically used or injected peptides from the longevity and biohacking area.
While cosmetic products primarily aim for superficial effects, many of the discussed longevity peptides intervene much deeper into metabolic and hormonal processes – with correspondingly different opportunities, but also risks.
In the longevity field, various peptides are discussed that are supposed to influence different biological processes. Important: Most of these so-called longevity peptides are not approved as anti-aging therapy, and the scientific data is limited.
Substances such as CJC-1295 and Ipamorelin are designed to stimulate the body’s natural release of growth hormone. Studies show that markers like IGF-1 can indeed be influenced.
The proposed benefits range from improved body composition to more “youthful” tissue characteristics. However, robust long-term data are lacking. It also cannot be ruled out that chronic stimulation of growth pathways may have unintended effects—for example, by promoting uncontrolled cell growth.
Classification: Biologically plausible, but not sufficiently supported for safe anti-aging use.
Peptides such as BPC-157 or TB-500 are particularly frequently discussed. In animal and cell studies, they show impressive effects on tissue healing - for example in tendons, skin, or the gastrointestinal tract.
These results are scientifically interesting, but so far can only be limitedly applied to humans. Clinical studies with clear endpoints are largely lacking.
Classification: Promising in research, but not yet clinically sufficiently validated.
Peptides like MOTS-c aim to improve mitochondrial function and make metabolism more efficient. Since these processes are closely linked to aging, the approach seems logical.
However, research is still in an early stage. Statements about actual effects on lifespan or disease risks in humans are currently not possible.
Classification: Theoretically exciting, but currently mainly experimental.
Substances such as Semax or Selank are associated with improved concentration, memory performance and stress resistance. In some countries, they are already used, often outside standardized approval procedures.
So far, large, controlled studies with clinically relevant endpoints are lacking.
Classification: Interesting, but not yet scientifically sufficiently validated.
Peptides like thymosin-α1 are specifically studied for their influence on the immune system and are also used therapeutically. However, their role in the context of anti-aging is not clearly defined.
Classification: Medically relevant, but not an established longevity approach.
A frequently discussed example in the field of longevity peptides is the peptide Epitalon, which is said to have an effect on telomeres — structures closely associated with cellular aging.
In Cell studies actually observed changes in telomere length. Such results are scientifically interesting, but they cannot be easily transferred to the human organism.
In addition, interventions in basic cellular mechanisms always carry potential risks – especially in connection with cell growth and cancer development.
Conclusion: There are indications of biological effects, but no convincing evidence that peptides actually extend lifespan in humans.
Many of the effects attributed to peptides involve known mechanisms such as inflammation, metabolism, or cellular stress. However, these processes can already be influenced by well-researched measures.
Regular exercise, a balanced diet, sufficient Sleep and the avoidance of risk factors like smoking have been proven to have a significant impact on the health span.
The crucial difference: For these factors, there are robust long-term data in humans – for most peptides, there are not.
In many countries, peptides used for medical purposes are regulated as prescription drugs. However, many of the substances discussed in the longevity and biohacking space are not approved and are often sold as “research chemicals.”
This creates a grey area: availability varies by country, and quality, safety, and legal status can differ significantly. In many cases, personal use falls outside clearly regulated frameworks
In addition to unclear effectiveness, safety aspects also play an important role. Products from the unregulated market can vary greatly in purity and dosage. There are also risks from improper use, such as with injections.
Biological effects are not automatically positive either: Interventions in growth signals or metabolic processes can have undesirable consequences – especially with long-term use.
Peptide-based medications are established and useful in clearly defined medical contexts, such as diabetes or obesity. Here, they can demonstrably contribute to improving health.
However, for most so-called longevity peptides, the following applies: Their use should – if at all – only under medical supervision or within the framework of clinical studies.
They are currently not suitable as a freely available anti-aging solution.
Peptides are a fascinating field of research with real biological potential. Especially in areas like regeneration, immunomodulation, and metabolism promising approaches are emerging.
At the same time, the evidence for anti-aging in humans remains limited. Robust long-term data is lacking, and legally, its use is not unproblematic.
The most important insight remains a well-known one: Sustainable health and longevity are primarily based on proven lifestyle factors—not on experimental shortcuts.
Peptides intended to specifically influence biological aging processes, such as through metabolism, inflammation, or cell repair.
So far there is no convincing evidence from human studies.
Only approved medications may be used regularly. Many other applications are in a gray area.
The data situation is limited, especially concerning long-term safety in humans.
